Mesa Total Assets from 2010 to 2026

MLAB Stock

USD 90.81 2.46 2.64%

Mesa Laboratories' Total Assets are increasing over the years with slightly volatile fluctuation. Overall, Total Assets are expected to go to about 523.3 M this year. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

1988-03-31

Previous Quarter

430.4 M

Current Value

434.8 M

Quarterly Volatility

207.3 M

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check Mesa Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mesa Laboratories' main balance sheet or income statement drivers, such as Interest Expense of 14.3 M, Total Revenue of 291 M or Gross Profit of 182.2 M, as well as many indicators such as Price To Sales Ratio of 2.92, Dividend Yield of 0.0059 or PTB Ratio of 2.38. Mesa financial statements analysis is a perfect complement when working with Mesa Laboratories Valuation or Volatility modules.

Build AI portfolio with Mesa Stock

Check out the analysis of Mesa Laboratories Correlation against competitors.

For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.

Analyzing Mesa Laboratories's Total Assets over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Total Assets has evolved provides context for assessing Mesa Laboratories's current valuation and future prospects.

Latest Mesa Laboratories' Total Assets Growth Pattern

Below is the plot of the Total Assets of Mesa Laboratories over the last few years. Total assets refers to the total amount of Mesa Laboratories assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Mesa Laboratories books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Mesa Laboratories' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mesa Laboratories' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 433.35 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Mesa Total Assets Regression Statistics

	Arithmetic Mean	310,509,230
	Geometric Mean	178,777,409
	Coefficient Of Variation	75.71
	Mean Deviation	212,772,949
	Median	171,733,000
	Standard Deviation	235,089,762
	Sample Variance	55267.2T
	Range	706.2M
	R-Value	0.85
	Mean Square Error	16098.3T
	R-Squared	0.73
	Significance	0.000014
	Slope	39,692,476
	Total Sum of Squares	884275.1T

Mesa Total Assets History

	2026	523.3 M
	2025	498.4 M
	2024	433.3 M
	2023	446.8 M
	2022	661.8 M
	2021	707.4 M
	2020	601.5 M

Other Fundumenentals of Mesa Laboratories

Intangibles To Total Assets

Mesa Laboratories Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Accounts Payable	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Good Will	Current Deferred Revenue	Long Term Debt	Net Tangible Assets	Deferred Long Term Liab	Long Term Debt Total	Capital Surpluse	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.92	0.55	-0.3	0.88	0.93	0.82	0.92	0.31	0.77	0.9	0.79	0.97	0.87	0.89	0.7	0.8	0.93	0.3	0.9	0.97	0.35	0.9
Total Stockholder Equity	0.92		0.24	0.06	0.65	0.71	0.84	0.74	0.03	0.65	0.7	0.62	0.85	0.64	0.82	0.75	0.59	0.72	0.08	0.73	0.94	0.6	0.72
Net Debt	0.55	0.24		-0.68	0.82	0.77	0.06	0.76	0.54	0.52	0.67	0.69	0.7	0.79	0.54	0.2	0.72	0.73	0.46	0.6	0.44	-0.48	0.64
Retained Earnings	-0.3	0.06	-0.68		-0.66	-0.61	-0.18	-0.52	-0.84	-0.28	-0.67	-0.47	-0.37	-0.7	-0.18	-0.02	-0.56	-0.61	-0.66	-0.58	-0.22	0.49	-0.63
Net Receivables	0.88	0.65	0.82	-0.66		0.97	0.58	0.96	0.64	0.67	0.96	0.87	0.93	0.97	0.72	0.51	0.86	0.97	0.56	0.88	0.79	-0.1	0.92
Total Liab	0.93	0.71	0.77	-0.61	0.97		0.67	0.96	0.54	0.77	0.97	0.85	0.95	0.97	0.82	0.55	0.88	0.99	0.48	0.94	0.86	0.05	0.95
Total Current Assets	0.82	0.84	0.06	-0.18	0.58	0.67		0.63	0.18	0.6	0.74	0.55	0.67	0.61	0.69	0.64	0.53	0.71	0.2	0.77	0.83	0.67	0.75
Accounts Payable	0.92	0.74	0.76	-0.52	0.96	0.96	0.63		0.49	0.79	0.92	0.86	0.96	0.93	0.8	0.64	0.86	0.94	0.45	0.85	0.85	0.04	0.9
Short Term Debt	0.31	0.03	0.54	-0.84	0.64	0.54	0.18	0.49		0.26	0.62	0.47	0.37	0.62	-0.03	0.04	0.52	0.56	0.79	0.53	0.22	-0.58	0.54
Intangible Assets	0.77	0.65	0.52	-0.28	0.67	0.77	0.6	0.79	0.26		0.68	0.63	0.73	0.67	0.74	0.73	0.64	0.73	0.25	0.71	0.73	0.22	0.67
Common Stock	0.9	0.7	0.67	-0.67	0.96	0.97	0.74	0.92	0.62	0.68		0.8	0.9	0.98	0.74	0.55	0.85	0.98	0.53	0.95	0.86	0.08	0.98
Property Plant Equipment	0.79	0.62	0.69	-0.47	0.87	0.85	0.55	0.86	0.47	0.63	0.8		0.83	0.83	0.67	0.51	0.78	0.85	0.45	0.7	0.65	-0.03	0.75
Good Will	0.97	0.85	0.7	-0.37	0.93	0.95	0.67	0.96	0.37	0.73	0.9	0.83		0.91	0.86	0.65	0.83	0.94	0.35	0.88	0.93	0.16	0.9
Current Deferred Revenue	0.87	0.64	0.79	-0.7	0.97	0.97	0.61	0.93	0.62	0.67	0.98	0.83	0.91		0.74	0.53	0.87	0.97	0.54	0.92	0.81	-0.05	0.95
Long Term Debt	0.89	0.82	0.54	-0.18	0.72	0.82	0.69	0.8	-0.03	0.74	0.74	0.67	0.86	0.74		0.63	0.67	0.8	0.04	0.78	0.87	0.47	0.77
Net Tangible Assets	0.7	0.75	0.2	-0.02	0.51	0.55	0.64	0.64	0.04	0.73	0.55	0.51	0.65	0.53	0.63		0.33	0.53	0.08	0.47	0.72	0.43	0.58
Deferred Long Term Liab	0.8	0.59	0.72	-0.56	0.86	0.88	0.53	0.86	0.52	0.64	0.85	0.78	0.83	0.87	0.67	0.33		0.86	0.46	0.84	0.72	-0.06	0.82
Long Term Debt Total	0.93	0.72	0.73	-0.61	0.97	0.99	0.71	0.94	0.56	0.73	0.98	0.85	0.94	0.97	0.8	0.53	0.86		0.5	0.96	0.86	0.08	0.95
Capital Surpluse	0.3	0.08	0.46	-0.66	0.56	0.48	0.2	0.45	0.79	0.25	0.53	0.45	0.35	0.54	0.04	0.08	0.46	0.5		0.46	0.23	-0.41	0.48
Short Long Term Debt	0.9	0.73	0.6	-0.58	0.88	0.94	0.77	0.85	0.53	0.71	0.95	0.7	0.88	0.92	0.78	0.47	0.84	0.96	0.46		0.89	0.19	0.94
Net Invested Capital	0.97	0.94	0.44	-0.22	0.79	0.86	0.83	0.85	0.22	0.73	0.86	0.65	0.93	0.81	0.87	0.72	0.72	0.86	0.23	0.89		0.45	0.87
Net Working Capital	0.35	0.6	-0.48	0.49	-0.1	0.05	0.67	0.04	-0.58	0.22	0.08	-0.03	0.16	-0.05	0.47	0.43	-0.06	0.08	-0.41	0.19	0.45		0.14
Capital Stock	0.9	0.72	0.64	-0.63	0.92	0.95	0.75	0.9	0.54	0.67	0.98	0.75	0.9	0.95	0.77	0.58	0.82	0.95	0.48	0.94	0.87	0.14

Click cells to compare fundamentals

About Mesa Laboratories Financial Statements

Mesa Laboratories stakeholders use historical fundamental indicators, such as Mesa Laboratories' Total Assets, to determine how well the company is positioned to perform in the future. Although Mesa Laboratories investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mesa Laboratories' assets and liabilities are reflected in the revenues and expenses on Mesa Laboratories' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mesa Laboratories. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	498.4 M	523.3 M
Intangibles To Total Assets	0.58	0.31

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill

When determining whether Mesa Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesa Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesa Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesa Laboratories Stock:

How To Invest In Mesa

Details

Is Mesa Stock a good investment?

Details

What is Mesa Laboratories' Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Mesa Laboratories Correlation against competitors.

For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.

You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesa Laboratories. Expected growth trajectory for Mesa significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Mesa Laboratories assessment requires weighing all these inputs, though not all factors influence outcomes equally.

Quarterly Earnings Growth

(0.29)

Dividend Share

0.64

Earnings Share

0.65

Revenue Per Share

45.096

Quarterly Revenue Growth

0.036

The market value of Mesa Laboratories is measured differently than its book value, which is the value of Mesa that is recorded on the company's balance sheet. Investors also form their own opinion of Mesa Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Mesa Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesa Laboratories' market value can be influenced by many factors that don't directly affect Mesa Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Understanding that Mesa Laboratories' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mesa Laboratories represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Mesa Laboratories' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Mesa Total Assets from 2010 to 2026

Latest Mesa Laboratories' Total Assets Growth Pattern

Mesa Total Assets Regression Statistics

Mesa Total Assets History

Other Fundumenentals of Mesa Laboratories

Mesa Laboratories Total Assets component correlations

About Mesa Laboratories Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY